Galera Therapeutics
IPO News: Filed S-1/A: Galera Therapeutics Launches 5mm Share IPO with $14.00 - $16.00 Marketing Range
Galera Therapeutics

Galera Therapeutics

NASDAQ: GRTX

Initial Filing Date: 10/11/19

Launch Date: 10/28/19

Price Range: $14.00 - $16.00

Shares Offered (Pre-Shoe | mm): 5.0

Primary Shares (mm): 5.0

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $75.0

% Secondary: 0.0%

Shares Outstanding (mm): 24.4

Market Value at Midpoint (mm):  $365.4

Offering as % of Market Value: 20.5%

Active Bookrunners: BAML | CITI | CS

Co-Manager: BTIG

Major Holders: New Enterprise Associates | Novartis Bioventures | Novo Holdings | Sofinnova Venture Partners | Blackstone 

Description: Galera is a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

Note: Emerging Growth Company

Reference Link:  S-1/A